Refractoriness to rituximab-based therapy and elevated...

  • Main
  • 2019 / 04
  • Refractoriness to rituximab-based therapy and elevated...

Refractoriness to rituximab-based therapy and elevated serum B2-microglobulin predict for inferior survival in marginal zone lymphoma

Sorigue, Marc, Bishton, Mark, Domingo-Domenech, Eva, McMillan, Andrew, Prusila, Roosa, García, Olga, Kuusisto, Milla, Condom, Maria, Tapia, Gustavo, Ribera, Josep-María, Kuittinen, Outi, Fox, Christop
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2019.1594212
Date:
April, 2019
File:
PDF, 1.14 MB
2019
Conversion to is in progress
Conversion to is failed